Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS)

被引：2
|
作者：
Butowski, N. A.
Lamborn, K.
Chang, S.
Page, M.
Rabbitt, J.
Fedoroff, A.
Parvataneni, R.
Nicol, S. J.
Thornton, D.
Prados, M. D.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3559
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE I/II STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (XRT) IN PATIENTS (PTS) WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, N.
    Lamborn, K.
    Chang, S.
    Page, M.
    Parvataneni, R.
    Chang, S.
    Liepa, A. M.
    Nicol, S.
    Thornton, D.
    Prados, M.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1073 - 1074
  • [2] PHASE II AND PHARMACOGENOMICS (PGX) STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, Nicholas A.
    Lamborn, Kathleen L.
    Polley, Mei-Yin C.
    Hsieh, Emily
    Kivett, Valerie
    Page, Margaretta S.
    Parvataneni, Rupa
    Nicol, Steve
    Thornton, Don
    Prados, Michael
    NEURO-ONCOLOGY, 2009, 11 (05) : 621 - 621
  • [3] Phase I/Pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed Glioblastoma Multiforme (GBM) or Gliosarcoma (GS)
    Butowski, Nicholas
    Lamborn, Kathleen
    Chang, Susan
    DeBoer, Rebecca
    Page, Margaretta
    Rabbitt, Jane
    Fedoroff, Ann
    Parvataneni, Rupa
    Kivett, Valene
    Nicol, Steuen J.
    Musib, Luna
    Leipa, Astra
    Thornton, Donald
    Prados, Michael
    NEUROLOGY, 2008, 70 (11) : A295 - A296
  • [4] Phase I/II study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM) or gliosarcoma
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Thornton, D.
    DeBoer, R.
    Page, M.
    Rabbitt, J.
    Parvanateni, R.
    Kivett, V.
    Nicol, S.
    Prados, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] PHASE II AND PHARMACOGENOMICS STUDY OF ENZASTAURIN PLUS TEMOZOLOMIDE AND RADIATION THERAPY IN PATIENTS WITH GLIOBLASTOMA MULTIFORME OR GLIOSARCOMA
    Butowski, Nicholas
    Lamborn, Kathleen
    Chang, Susan
    Hsieh, Emily
    Rabbitt, Jaric
    Fedoroff, Anne
    Parvataneni, Rupa
    Nicol, Steven
    Liepa, Astra
    Thornton, Donald E.
    Prados, Michael
    NEURO-ONCOLOGY, 2008, 10 (05) : 832 - 832
  • [6] Phase II and pharmacogenomics study of enzastaurin plus temozolomide and radiation therapy in patients with glioblastoma multiforme or gliosarcoma
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Hsieh, E.
    Fedoroff, A.
    Parvataneni, R.
    Nicol, S.
    Liepa, A.
    Thornton, D.
    Prados, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei Yin
    Parvataneni, R.
    Hristova-Kazmierski, Maria
    Musib, Luna
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2010, 12 (06) : 608 - 613
  • [8] Phase I/pharmacokinetic (PK) study of enzastaurin plus temozolomide during and following radiation therapy in patients (PTS) with newly diagnosed glioblastoma multiforme (GBM) or gliosarcoma
    Butowski, Nicholas
    Lamborn, Kathleen
    Chang, Susan
    DeBoer, Rebecca
    Page, Margaretta
    Rabbitt, Jane
    Fedoroff, Anne
    Parvataneni, Rupa
    Kivett, Valerie
    Nicol, Steven
    Musib, Luna
    Liepa, Astra
    Thornton, Donald E.
    Prados, Michael
    NEURO-ONCOLOGY, 2007, 9 (04) : 515 - 515
  • [9] Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei-Yin
    Pieper, Russell
    Costello, Joseph F.
    Vandenberg, Scott
    Parvataneni, Rupa
    Nicole, Angelina
    Sneed, Patricia K.
    Clarke, Jennifer
    Hsieh, Emily
    Costa, Bruno M.
    Reis, Rui M.
    Hristova-Kazmierski, Maria
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2011, 13 (12) : 1331 - 1338
  • [10] Phase I/pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
    Butowski, Nicholas
    Lamborn, Kathleen
    Chang, Susan
    Page, Margaretta
    Rabbitt, Jane
    Federoff, Anne
    Parvataneni, Rupa
    Nicol, Steven
    Musib, Luna
    Liepa, Astra
    Thornton, Donald
    Prados, Michael
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3345S - 3345S
12345